Moody's lowers Merck's long-term debt rating
Moody's Investors Service on Tuesday lowered the long-term debt ratings of drug maker Merck & Co. Full story
Higher prices for MS drug help drug firm Merck
Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit. Full story
Merck sales representative claims sexual bias, seeks over $100 million
(Reuters) - A sales representative for Merck & Co. <MRK.N> filed a more than $100 million sex discrimination lawsuit against the drugmaker on Thursday, claiming that it particularly discriminates against pregnant employees and women with children. Full story
Merck plays up consumer products in new campaign
Merck & Co. is playing up its consumer-product division with a new ad campaign focusing on active families. Full story
Fitch affirms Merck ratings but downgrades outlook
Fitch Ratings said Friday it's affirmed its ratings for Merck & Co., but downgraded its rating outlook for the world's third-biggest drugmaker to "Negative" from "Positive." Full story
On the Call: Merck R&D director Roger Perlmutter
During a conference call with analysts to discuss first-quarter results Wednesday, drugmaker Merck & Co. introduced its new head of research and development, Roger Perlmutter, a former Merck research executive who had run R&D at biotech drugmaker Amgen Inc. for more than a decade. Analysts asked Per Full story
Sponsored Links
Articles
Video
Merck Shares Spike
The FMHR traders debate how to play Yum! Brands after the company's China sales fell less-than-expected; and Steve Grasso of Stuart Frankel offers his opinion on whether Merck has more upside ahead.
Merck Hits New 52-Week High
Merck showed big numbers in this morning's earnings report, with CNBC's Seema Mody.
New sleeping pill touts fewer side effects
Merck announced results of a study indicating their new drug, suvorexant, made people fall asleep 40 percent faster and 40 percent longer than placebo without a lingering drowsy feeling upon waking. NBC’s Robert Bazell reports.
advertisement | ad info
Related Photos
Handout of Merck cholesterol drug Vytorin
This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Vytorin. REUTERS/Courtesy of Merck/Handout
Branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt
A branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt March 7, 2012. REUTERS/Alex Domanski
The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt
The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt March 7, 2012. REUTERS/Alex Domanski
